JPH0252220B2 - - Google Patents
Info
- Publication number
- JPH0252220B2 JPH0252220B2 JP58503487A JP50348783A JPH0252220B2 JP H0252220 B2 JPH0252220 B2 JP H0252220B2 JP 58503487 A JP58503487 A JP 58503487A JP 50348783 A JP50348783 A JP 50348783A JP H0252220 B2 JPH0252220 B2 JP H0252220B2
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- red blood
- blood cells
- strip
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000003743 erythrocyte Anatomy 0.000 description 50
- 239000012528 membrane Substances 0.000 description 49
- 210000004369 blood Anatomy 0.000 description 48
- 239000008280 blood Substances 0.000 description 48
- 239000011148 porous material Substances 0.000 description 33
- 230000002745 absorbent Effects 0.000 description 29
- 239000002250 absorbent Substances 0.000 description 29
- 239000012530 fluid Substances 0.000 description 26
- 238000001914 filtration Methods 0.000 description 23
- 238000010521 absorption reaction Methods 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- 238000005534 hematocrit Methods 0.000 description 10
- 208000007056 sickle cell anemia Diseases 0.000 description 8
- 238000005259 measurement Methods 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 238000011085 pressure filtration Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000009601 hereditary spherocytosis Diseases 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US432635DEEDK | 1982-10-04 | ||
| PCT/US1983/001544 WO1984001429A1 (en) | 1982-10-04 | 1983-10-04 | Process and device for erythrocyte deformation determination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59501961A JPS59501961A (ja) | 1984-11-22 |
| JPH0252220B2 true JPH0252220B2 (enrdf_load_stackoverflow) | 1990-11-09 |
Family
ID=22175473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58503487A Granted JPS59501961A (ja) | 1982-10-04 | 1983-10-04 | 赤血球濾過装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59501961A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07272543A (ja) * | 1994-01-03 | 1995-10-20 | Internatl Business Mach Corp <Ibm> | 側縁部を補強したリボン・ケーブル |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3781677T2 (de) * | 1986-10-17 | 1993-04-01 | Baxter Int | Verfahren und vorrichtung zur bestimmung von haematokrit in einem system zur bearbeitung von blutbestandteilen. |
-
1983
- 1983-10-04 JP JP58503487A patent/JPS59501961A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07272543A (ja) * | 1994-01-03 | 1995-10-20 | Internatl Business Mach Corp <Ibm> | 側縁部を補強したリボン・ケーブル |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59501961A (ja) | 1984-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4491012A (en) | Method for measuring erythrocyte deformability | |
| US3552929A (en) | Diagnosis means | |
| Buchan | Evaluation and modification of whole blood filtration in the measurement of erythrocyte deformability in pregnancy and the newborn | |
| Kikuchi et al. | Improved filtration method for red cell deformability measurement | |
| EP0390984B1 (en) | Oral fluid collection article | |
| Koutsouris et al. | Determination of erythrocyte transit times through micropores. I-Basic operational principles | |
| JPH07502118A (ja) | 関連血液パラメータの定量方法と定量装置 | |
| US20170074893A1 (en) | Devices and methods for analyzing a blood coagulation property | |
| US7115421B2 (en) | Method and device for measurement of hematocrit | |
| US7908906B2 (en) | Fluidic test apparatus and method | |
| Harada et al. | A new method of osmotic fragility test of erythrocytes with coil planet centrifuge | |
| JPH0252220B2 (enrdf_load_stackoverflow) | ||
| Mangos | Transductal fluxes of Na, K, and water in the human eccrine sweat gland | |
| US11525801B2 (en) | Strip structure for measuring potassium ions | |
| SWANK et al. | Blood cell aggregation and screen filtration pressure | |
| US4402216A (en) | Erythrocyte deformability monitor | |
| Mitsubayashi et al. | Measurement of tear electrolyte concentration and turnover rate using a flexible conductimetric sensor | |
| Leblond et al. | Evaluation of a simplified filtration technique for the routine measurement of erythrocyte deformability | |
| Lucas et al. | Comparison of silver and polycarbonate membranes for measurement of erythrocyte filterability | |
| Johnsson et al. | Studies on red cell flexibility in spherocytosis using a polycarbonate membrane filtration method | |
| Ritchie | Filtration of dilute erythrocyte suspension as a measure of erythrocyte deformability and its relationship to blood glucose control in diabetes mellitus | |
| Nir et al. | The osmotic fragility of human leucocytes in normal and in some pathological conditions | |
| Athanassiou et al. | Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes | |
| SU1174855A1 (ru) | Способ определени неспецифической иммунологической активности полиморфно дерных лейкоцитов периферической крови | |
| NAOASAWA et al. | Graphic analysis of osmotic fragility of erythrocytes |